Aerovate Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aerovate Therapeutics generated cash of -$56,778,000, which is less than the previous year. Cash used in financing activities reached the amount of $45,996,000 last year. Net change in cash is therefore $1,094,000.
Cash Flow
| 2019 | -2.78M | 0 | 2.5M |
|---|---|---|---|
| 2020 | -7.85M | 0 | 8.91M |
| 2021 | -27.39M | -113.43M | 190.45M |
| 2022 | -39.12M | 6.92M | 396K |
| 2023 | -56.77M | 11.87M | 45.99M |
AVTE Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 22.39M | 54.19M | 4.57M | 3.51M | 3.79M |
Operating activities | |||||
Net income | -75.52M | -51.51M | -22.96M | -9.61M | -3.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 96K | 68K | 15K | 1K | 0 |
Stock-based compensation expense | 11.90M | 5.47M | 2.04M | 58K | 0 |
| Deferred income tax benefit | 11.90M | 5.47M | 2.04M | 58K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -164K | 1.36M | 609K | 37K | 436K |
Cash generated by operating activities | -56.77M | -39.12M | -27.39M | -7.85M | -2.78M |
Investing activities | |||||
Purchases Of Investments | -123.98M | -147.62M | -113.25M | 0 | 0 |
Investments In Property Plant And Equipment | -142K | -195K | -181K | 0 | 0 |
Acquisitions Net | 0 | -7.12K | 0 | 0 | 0 |
Cash generated by investing activities | 11.87M | 6.92M | -113.43M | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 44.88M | 150K | 126.94M | 6.41M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -2.5M | 0 |
Cash used in financing activities | 45.99M | 396K | 190.45M | 8.91M | 2.5M |
Net Change In Cash | 1.09M | -31.8M | 49.62M | 1.05M | -281K |
Cash at end of period | 23.49M | 22.39M | 54.19M | 4.57M | 3.51M |
| Data source | Data source | Data source |